ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Eukaryotic Gene Expression
インパクトファクター: 1.841 5年インパクトファクター: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017018935
pages 53-62

Applications of Three-Dimensional Cell Cultures in the Early Stages of Drug Discovery, Focusing on Gene Expressions, Drug Metabolism, and Susceptibility

Maddaly Ravi
Department of Human Genetics, Faculty of Biomedical Sciences, Technology, and Research, Sri Ramachandra University, Porur, Chennai 600116, India

要約

Three-dimensional (3D) cell cultures represent advances in the way in which cells are grown in vitro, and they are gaining ground for a variety of applications. Advantages of 3D systems include reliable and realistic study endpoints. Cells grown in 3D conditions mimic in vivo conditions to an extent that is not possible with traditional 2D cell-culture methods. One major area in which 3D cell cultures have proven to make a difference is with drug discovery. The facets taken advantage of for drug discovery are the cells' complex microenvironment, including the production of extracellular matrices, altered gene expressions and their protein products, drug metabolism, and susceptibility to drugs when compared to 2D cultures. Altered protein and gene expressions are useful for drug-target identification. The susceptibility of 3D cultured cells for drug-induced effects can be used to obtain realistic data in a dose-dependent manner that can aid in identifying effective drug dosage. This review presents the contributions of 3D cell cultures for drug discovery, taking into consideration gene and protein expressions, drug metabolism, and susceptibility to drugs as the major focus points.


Articles with similar content:

Colloidal Drug Delivery Systems: Current Status and Future Directions
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 2
Goutam Rath, Tarun Garg, Amit Kumar Goyal
Liquid Biopsies in the Management of Bladder Cancer: Next-Generation Biomarkers for Diagnosis, Surveillance, and Treatment-Response Prediction
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 5-6
Monica Cheng, Hristos Z. Kaimakliotis, Shaobo Zhang, Catherine R. Miller, Antonio Lopez-Beltran, Michael O. Koch, Yu Yang, Rodolfo Montironi, Liang Cheng
Neural Tissue Engineering and Biohybridized Microsystems for Neurobiological Investigation In Vitro (Part 1)
Critical Reviews™ in Biomedical Engineering, Vol.39, 2011, issue 3
D. Kacy Cullen, Jelena Vukasinovic, Michelle C. LaPlaca, Varadraj N. Vernekar, John A. Wolf
Nanocapsule Technology: A Review
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.19, 2002, issue 2
Elias Fattal, Gillian Barratt, Patrick Couvreur, Christine Vauthier
Targeted Breast Cancer Nanotherapeutics: Options and Opportunities with Estrogen Receptors
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 5
Rishi Paliwal, Govind P Agrawal, Shivani Rai Paliwal, Suresh P. Vyas